Solute carrier transporter family protein (SLC)

Solute carrier transporter family protein (SLC) refers to a superfamily of over 400 membrane transporters, classified into at least 66 families, that are responsible for the movement of a wide range of solutes—including ions, amino acids, sugars, neurotransmitters, and drugs—across cellular membranes. SLCs are mostly secondary active or facilitative transporters, relying on gradient coupling, and are distinct from primary active transporters like ATP-binding cassette (ABC) proteins and ion channels. SLC transporters are critical for cellular and systemic homeostasis, drug absorption, and tissue distribution, particularly at barriers like the blood-brain barrier and in organs such as the kidney and liver. Dysregulation or mutation of SLC genes is implicated in numerous human diseases, including epilepsy, neurodegenerative disorders, and cancer. While SLCs are increasingly recognized as drug targets and as determinants of drug disposition, they remain underexploited compared to receptors and enzymes, largely due to the complexity of their substrate specificities and transport mechanisms. Genetic variations, expression levels, and localization of specific SLC family members can influence disease risk and therapeutic response, making them valuable as therapeutic targets and clinical biomarkers[1][2][3][4][5].

Other names

Solute carrier family proteinsSLC transporterSLC proteinSolute carrierSLC superfamily

Inhibition of solute uptake Competitive inhibition of substrate transport Modulation of ion gradients Facilitation of drug entry across the blood-brain barrier